Allcredit.cards Launches Comprehensive Database of 3,500 US Credit Cards Oxurion Publishes First Half 2023 Results
Regulated Information Leuven, BELGIUM, Boston, MA, US – September 29, 2023 – 7.00 PM CET…
SmartStop Self Storage Continues Its Dedicated Support for the Breast Cancer Research Foundation for a Remarkable Sixth Consecutive Year
LADERA RANCH, Calif.–(BUSINESS WIRE)–SmartStop Self Storage REIT, Inc. (“SmartStop” or the “Company”), a self-managed and…
Enterprise to Participate in Wolfe Research Utilities, Midstream & Clean Energy Conference
HOUSTON–(BUSINESS WIRE)–Enterprise Products Partners L.P. (NYSE: EPD) announced today it will host virtual investor meetings…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of GigaCloud Technology Inc. (GCT) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
The AZEK® Company Announces Peter Clifford to Take on Dual Role as Chief Operations Officer and Chief Financial Officer; Promotes Randy Herth to Chief Accounting Officer and Treasurer
CHICAGO–(BUSINESS WIRE)–The AZEK Company Inc. (NYSE: AZEK) (“AZEK” or the “Company”), the industry-leading manufacturer of…
Total number of shares and voting rights in Zealand Pharma at September 29, 2023
Company announcement – No. 36 / 2023 Total number of shares and voting rights in…
Fathom Digital Manufacturing 1-for-20 Reverse Stock Split Becomes Effective
HARTLAND, Wis.–(BUSINESS WIRE)–Fathom Digital Manufacturing Corp. (“Fathom” or the “Company”) (NYSE: FATH), an industry leader…
Novartis completes divestment of ‘front of eye’ ophthalmology assets
Divestment includes Xiidra®, on-market treatment for dry eye disease and additional ophthalmic investigational therapies Novartis…
Sernova Presents Compelling New Data on the Cell Pouch System™ as a Promising Treatment for Post-Operative Hypothyroidism at the 2023 American Thyroid Association Annual Meeting
Proof-of-concept data supports the clinical evaluation of the Cell Pouch System as a potential treatment…
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
The combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing…
Deveron Places No, 30th on The Globe and Mail’s Fifth-Annual Ranking of Canada’s Top Growing Companies
Toronto, Ontario–(Newsfile Corp. – September 29, 2023) – Deveron Corp. (TSXV: FARM) is pleased to…
GrafTech Announces Leadership Update
BROOKLYN HEIGHTS, Ohio–(BUSINESS WIRE)–GrafTech International Ltd. (NYSE:EAF) (“GrafTech” or the “Company”) announced today that Marcel…
JFrog Announces CFO Transition
Company Appoints Ed Grabscheid as new CFO, Jacob Shulman to depart as CFO at Fiscal…
TechnipFMC Awarded Flexible Pipe Contract by Petrobras
NEWCASTLE & HOUSTON–(BUSINESS WIRE)–TechnipFMC (NYSE: FTI) has been awarded a significant(1) contract to supply flexible…
New Mountain Finance Corporation Schedules its Third Quarter 2023 Earnings Release and Conference Call
NEW YORK–(BUSINESS WIRE)–New Mountain Finance Corporation (Nasdaq: NMFC) (“New Mountain” or “the Company”) announced today…
Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023
DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023
DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review
If approved, odronextamab would be the first and only bispecific antibody approved in both FL…
Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review
If approved, odronextamab would be the first and only bispecific antibody approved in both FL…
Dyadic to Present at Industry and Investor Events in October
JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…